Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1998
12/03/1998WO1998053818A1 Sulfonamides as cell adhesion inhibitors
12/03/1998WO1998053817A1 Biarylalkanoic acids as cell adhesion inhibitors
12/03/1998WO1998053814A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998WO1998053812A1 Inhibitors of naaladase enzyme activity
12/03/1998WO1998053811A1 Method and compositions for administering taxanes orally to human patients
12/03/1998WO1998053804A1 Methods and compositions for targeting compounds to muscle
12/03/1998WO1998053801A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998WO1998053702A1 Method for treating a lactic raw material containing gmp
12/03/1998WO1998053698A1 Uses of oil bodies
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998045332A3 Humanized antibodies and methods for forming humanized antibodies
12/03/1998WO1998045331A3 Anti-vegf antibodies
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998041631A3 β-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER
12/03/1998WO1998041238A3 Methods and kits for treating and diagnosing leiomyomas
12/03/1998WO1998040486A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998040478A3 Antisense inhibition of human stat-6
12/03/1998WO1998039440A3 CALCIUM INDEPENDENT RECEPTOR OF α-LATROTOXIN, CHARACTERIZATION AND USES THEREOF
12/03/1998WO1998038302A3 TETRODOTOXIN-SENSITIVE SODIUM CHANNEL α-SUBUNIT
12/03/1998WO1998035684A3 Methods for detection of kaposi's sarcoma-associated herpesvirus-like virus
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998DE19722952A1 Use of polymers comprising units of fluorine atom(s) on carbon atom
12/03/1998DE19722888A1 Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten Human CD28 specific monoclonal antibodies for the antigen non-specific activation of T-lymphocytes
12/03/1998DE19719652A1 Use of tissue factor
12/03/1998CA2292790A1 Human tumor necrosis factor receptor tr10
12/03/1998CA2291960A1 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998CA2291894A1 Antimicrobial peptides derived from ubiquicidine
12/03/1998CA2291881A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291856A1 Cyclic crf antagonist peptides
12/03/1998CA2291839A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998CA2291778A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998CA2291765A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/03/1998CA2291762A1 Biarylalkanoic acids as cell adhesion inhibitors
12/03/1998CA2291720A1 Pharmaceutical compositions comprising a soluble laminin receptor precursor of a compound which blocks the interaction of the laminin receptor precursor and prpsc or prpc
12/03/1998CA2291708A1 Sulfonamides as cell adhesion inhibitors
12/03/1998CA2291698A1 Osf2/cbfa1 compositions and methods of use
12/03/1998CA2291595A1 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998CA2291590A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998CA2291510A1 Modulators of morphogen expression and methods of identifying the same
12/03/1998CA2291484A1 Gene and amino acid sequences for novel transcription factor
12/03/1998CA2291482A1 Tissue plasminogen activator-like protease
12/03/1998CA2291451A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998CA2291258A1 Inhibitors of naaladase enzyme activity
12/03/1998CA2291221A1 32 human secreted proteins
12/03/1998CA2290954A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998CA2290943A1 New human dp1 homolog
12/03/1998CA2288967A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide
12/03/1998CA2288840A1 Integrin-targeting vectors having transfection activity
12/03/1998CA2288737A1 Pharmaceutical preparation comprising vwf propeptide
12/03/1998CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33
12/02/1998EP0881299A1 Monoclonal antibody that recognizes antigens present on the surface of endothelial cell of tumor vessel
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881297A2 Histidine kinase
12/02/1998EP0881296A2 Histidine kinase
12/02/1998EP0881295A2 Histidine kinase
12/02/1998EP0881294A2 HOEFCC11, a HAS2 splicing variant
12/02/1998EP0881292A2 Streptocococcus pneumoniae peptide release factor
12/02/1998EP0881291A2 CBS2 polypeptides, members of the guanine exchange factor family
12/02/1998EP0881290A2 Neurotransmitter transporter HPDDV78
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0881286A2 Histidine kinase
12/02/1998EP0881285A1 D-Alanine transferase
12/02/1998EP0881230A2 Urea and thiourea derivatives of antibiotic glycopeptides
12/02/1998EP0881229A2 Alkylated antibiotic hexapeptides
12/02/1998EP0880971A2 Macrophage stimulating protein for the treatment of pathologies of the nervous system
12/02/1998EP0880970A1 Pharmaceutical compositions comprising an anticytokine
12/02/1998EP0880969A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/02/1998EP0880968A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/02/1998EP0880902A1 Process for treating a raw whey material
12/02/1998EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
12/02/1998EP0880596A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells
12/02/1998EP0880591A1 Thrombin muteins as antidotes for thrombin inhibitors
12/02/1998EP0880586A1 Lyst1 and lyst2 gene compositions and methods of use
12/02/1998EP0880584A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
12/02/1998EP0880583A1 Estrogen response element binding proteins and nucleotides encoding therefor
12/02/1998EP0880542A2 Substrates and inhibitors for cysteine protease ich-1
12/02/1998EP0880541A1 Derivatives of antibiotic ge2270 factors
12/02/1998EP0880364A2 Contraceptive release systems with antibacterial and/or antiviral effect
12/02/1998EP0880362A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
12/02/1998EP0880360A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
12/02/1998EP0880359A1 Nima interacting proteins
12/02/1998EP0880358A1 Inhibitors of cyclophilin rotamase activity
12/02/1998EP0880356A1 Antimicrobial peptides and methods of use
12/02/1998EP0880355A1 METHODS OF MODULATING INFLAMMATORY CYTOKINES IN THE CNS USING TGF-$g(b)
12/02/1998EP0869975A4 Assay for and uses of peptide hormone receptor ligands
12/02/1998EP0804466B1 Novel tetrapeptides, their manufacture and use
12/02/1998EP0789561A4 Oral cyclosporin formulations
12/02/1998EP0771210A4 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ -g(g)1 CHAIN
12/02/1998EP0757249A4 Method of determining the suppressor cell component of the immune status of an individual and means for carrying out the same
12/02/1998EP0752875A4 Glioblastoma-derived angiogenesis inhibiting factor
12/02/1998EP0750635B1 Peptides inhibiting the release of pepsine
12/02/1998EP0743953B1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
12/02/1998EP0717753B1 Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
12/02/1998EP0691986B1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS
12/02/1998EP0545991B1 Peptides that block human immunodeficiency virus infections and methods of use thereof
12/02/1998EP0527785B1 Improvements relating to the detection of viruses
12/02/1998EP0515571B1 Hybrid reagents capable of selectively releasing molecules into cells
12/02/1998CN1200763A New adhesion from helicobactor pylori
12/02/1998CN1200737A Recombinant anti-CD4 antibodies for human therapy
1 ... 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 ... 3163